EPISODE · Jul 17, 2024 · 1H 12M
Nasal Lightsaber: The Force Behind Photodisinfection
from Sickboy
Shedding light on the invisible enemy, Dr. Nicholas Lobel reveals the illuminating potential of photodisinfection to transform healthcare. Dr. Loebel serves as President and Chief Technology Officer (CTO) of Ondine Biomedical. Beyond the growing ineffectiveness of antibiotics, Dr. Loebel delves into the brilliance of using light to zap harmful microbes. Get ready to nerd out with the guys as they learn about how photodisinfection targets bacteria with laser-like precision on various surfaces and even within body cavities (right up the ol' schnoz), distinguishing itself from other light-based treatments. Dr. Lobel highlights the critical role of nasal decolonization in preventing hospital-acquired infections, showcasing impressive success stories and the untapped potential of this approach.Catch the full video version of this episode on YouTube!Follow Sickboy on Instagram, TikTok and Discord
What this episode covers
Shedding light on the invisible enemy, Dr. Nicholas Lobel reveals the illuminating potential of photodisinfection to transform healthcare. Dr. Loebel serves as President and Chief Technology Officer (CTO) of Ondine Biomedical. Beyond the growing ineffectiveness of antibiotics, Dr. Loebel delves into the brilliance of using light to zap harmful microbes. Get ready to nerd out with the guys as they learn about how photodisinfection targets bacteria with laser-like precision on various surfaces and even within body cavities (right up the ol' schnoz), distinguishing itself from other light-based treatments. Dr. Lobel highlights the critical role of nasal decolonization in preventing hospital-acquired infections, showcasing impressive success stories and the untapped potential of this approach.Catch the full video version of this episode on YouTube!Follow Sickboy on Instagram, TikTok and Discord
NOW PLAYING
Nasal Lightsaber: The Force Behind Photodisinfection
No transcript for this episode yet
Similar Episodes
Sep 20, 2023 ·42m
Sep 15, 2023 ·30m
Aug 9, 2023 ·85m
Jul 12, 2023 ·35m
Jul 9, 2023 ·40m